Interventional cardiology in a whole new light

Open menu

News & Events

Opsens appoints Denis Harrington to its Board of Directors

20 January 2015

Quebec City, Quebec, January 20, 2015 – Opsens Inc. (“Opsens”) (TSXV:OPS) is pleased to announce the appointment of Mr. Denis Harrington as a Director of the Company. Denis Harrington owns a management and strategy consulting firm he founded in 2012. Prior to managing his own company, he worked for several medical companies and, among other…

Read more

Opsens – results of first quarter 2015

19 January 2015

Quebec City, Quebec, January 20, 2015 – Opsens Inc. (“Opsens”) (TSXV:OPS) today released the results of its first quarter ended November 30, 2014. Highlights of recent months Receipt of CE marking for the sale of the FFR Products (“OptoWire and OptoMonitor”) in Europe; Receipt of Shonin approval from Japan’s Ministry Of Health, Labor and Welfare…

Read more

Opsens announces first use of its FFR products in Europe with DR De Bruyne

12 January 2015

Quebec City, Quebec, January 12 , 2015 – Opsens Inc . (“Opsens ”) (TSXV:OPS) is pleased to announce the first use of its Fractional Flow Reserve (“FFR”) products in Europe by the “founding fathers” of FFR, namely Dr. Bernard De Bruyne at the Cardiovascular Center Aalst, Belgium and, shortly, by Professor Nico Pijls, at the…

Read more